Mal-Deferoxamine is a maleamide (Mal)-containing Deferoxamine (HY-B1625). Mal selectively covalently binds to sulfur groups to produce a linking reaction. Mal-Deferoxamine can be combined with radionuclides to synthesize radionuclide drug conjugates (RDCs). RDCs have the ability to specifically target biomolecules and can be used in medical imaging or therapy.[1].
Molekulargewicht:
711.80
Reinheit:
95
CAS Nummer:
[1638156-31-6]
Formel:
C32H53N7O11
Target-Kategorie:
Akt,Apoptosis,Autophagy,HIF/HIF Prolyl-Hydroxylase,Radionuclide-Drug Conjugates (RDCs),Reactive Oxygen Species (ROS)
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten